HR 349 United States House · 117th Congress

Coronavirus Vaccine and Therapeutic Development Act of 2021

Summary

Coronavirus Vaccine and Therapeutic Development Act of 2021 This bill directs the Department of Health and Human Services (HHS) to increase the supply of vaccines and medical products that prevent or control COVID-19 (i.e., coronavirus disease 2019). To increase supplies, HHS must, as appropriate, award grants and enter other transactions to expand relevant research, procurement, and production activities. HHS must report to Congress on these actions. The report must assess and detail plans to enhance the supply chain and manufacturing capacity for the vaccines and products. It must also include plans to support domestic and international vaccination programs.

Bill status in committee 1 of 4 stages cleared

Introduction

Jan 2021

Committee Review

Floor Vote

President

Introduced Jan 19, 2021 Last action Feb 5, 2021

Floor votes

How they voted

No floor votes recorded yet.

Full legislative history

Actions timeline

Total actions

Key actions

Committee

Feb 2, 2021

Committee

Referred to the Subcommittee on Health.

lower

Jan 19, 2021

Committee

Referred to the House Committee on Energy and Commerce.

lower

Jan 19, 2021

Introduced

Introduced in House

lower

1 primary · 11 co-sponsors

Sponsors

Role

Legislator

Party

State

District